{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:29:40Z","timestamp":1791804580104,"version":"4.3.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Association Neurofibromatoses et Recklinghausen"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,18]]},"DOI":"10.1093\/neuonc\/noy009","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T07:12:46Z","timestamp":1517296366000},"page":"917-929","source":"Crossref","is-referenced-by-count":66,"title":["Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis"],"prefix":"10.1093","volume":"20","author":[{"given":"Camille","family":"Louvrier","sequence":"first","affiliation":[{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"},{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Briand-Suleau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"},{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Cohen","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nitschk\u00e9","sequence":"additional","affiliation":[{"name":"Bioinformatic Platform, INSERM UMR 1163, Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Imagine Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Nectoux","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Orhant","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Zordan","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique M\u00e9dicale, H\u00f4pital Pellegrin, CHU Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[{"name":"Laboratoire MRGM, INSERM U1211, Universit\u00e9 Bordeaux, Bordeaux, France"},{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Goutagny","sequence":"additional","affiliation":[{"name":"Service de Neurochirurgie, H\u00f4pital Beaujon, Assistance Publique-H\u00f4pitaux de Paris, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lallemand","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vidaud","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"},{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"},{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[{"name":"Service de Neurochirurgie, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Parfait","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes\u2013Sorbonne, Paris Cit\u00e9, Facult\u00e9 de Pharmacie de Paris, Paris, France"},{"name":"Service de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"key\n\t\t\t\t20180618200125_CIT0001","first-page":"16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"key\n\t\t\t\t20180618200125_CIT0002","first-page":"847","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"issue":"12","key":"key\n\t\t\t\t20180618200125_CIT0003","first-page":"841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"issue":"16","key":"key\n\t\t\t\t20180618200125_CIT0004","first-page":"2743","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Cooper","year":"2014","journal-title":"FEBS Lett"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0005","first-page":"297","article-title":"The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene","volume":"27","author":"Baser","year":"2006","journal-title":"Hum Mutat"},{"issue":"1","key":"key\n\t\t\t\t20180618200125_CIT0006","first-page":"1","article-title":"Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings","volume":"28","author":"Ahronowitz","year":"2007","journal-title":"Hum Mutat"},{"issue":"7","key":"key\n\t\t\t\t20180618200125_CIT0007","first-page":"529","article-title":"Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2","volume":"41","author":"Tsilchorozidou","year":"2004","journal-title":"J Med Genet"},{"issue":"6","key":"key\n\t\t\t\t20180618200125_CIT0008","first-page":"594","article-title":"Mutation type and position varies between mosaic and inherited NF2 and correlates with disease severity","volume":"83","author":"Evans","year":"2013","journal-title":"Clin Genet"},{"issue":"7","key":"key\n\t\t\t\t20180618200125_CIT0009","first-page":"424","article-title":"Mosaicism in neurofibromatosis type 2: an update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification","volume":"44","author":"Evans","year":"2007","journal-title":"J Med Genet"},{"issue":"6","key":"key\n\t\t\t\t20180618200125_CIT0010","first-page":"459","article-title":"Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring","volume":"40","author":"Moyhuddin","year":"2003","journal-title":"J Med Genet"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0011","first-page":"109","article-title":"Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas","volume":"40","author":"Kluwe","year":"2003","journal-title":"J Med Genet"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0012","first-page":"805","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"3","key":"key\n\t\t\t\t20180618200125_CIT0013","first-page":"405","article-title":"Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria","volume":"161A","author":"Plotkin","year":"2013","journal-title":"Am J Med Genet Part A"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0014","first-page":"182","article-title":"Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas","volume":"46","author":"Piotrowski","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"key\n\t\t\t\t20180618200125_CIT0015","first-page":"449","article-title":"Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants","volume":"128","author":"Hutter","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"key\n\t\t\t\t20180618200125_CIT0016","first-page":"73","article-title":"Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation","volume":"11","author":"Bacci","year":"2010","journal-title":"Neurogenetics"},{"issue":"8","key":"key\n\t\t\t\t20180618200125_CIT0017","first-page":"567","article-title":"SMARCB1 mutations are not a common cause of multiple meningiomas","volume":"47","author":"Hadfield","year":"2010","journal-title":"J Med Genet"},{"issue":"3","key":"key\n\t\t\t\t20180618200125_CIT0018","first-page":"295","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0019","first-page":"436","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014","journal-title":"J Pathol"},{"issue":"3","key":"key\n\t\t\t\t20180618200125_CIT0020","first-page":"520","article-title":"Loss of SUFU function in familial multiple meningioma","volume":"91","author":"Aavikko","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0021","first-page":"368","article-title":"Mutation scanning of the NF2 gene: an improved service based on meta-PCR\/sequencing, dosage analysis, and loss of heterozygosity analysis","volume":"8","author":"Wallace","year":"2004","journal-title":"Genet Test"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0022","first-page":"384","article-title":"Screening for large mutations of the NF2 gene","volume":"42","author":"Kluwe","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"key\n\t\t\t\t20180618200125_CIT0023","article-title":"Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy","author":"Pasmant","year":"2015","journal-title":"Neuro-Chirurgie"},{"issue":"5","key":"key\n\t\t\t\t20180618200125_CIT0024","first-page":"596","article-title":"Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations","volume":"23","author":"Pasmant","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"key\n\t\t\t\t20180618200125_CIT0025","first-page":"397","article-title":"Droplet digital PCR combined with minisequencing, a new approach to analyze fetal DNA from maternal blood: application to the non-invasive prenatal diagnosis of achondroplasia","volume":"36","author":"Orhant","year":"2016","journal-title":"Prenat Diagn"},{"issue":"5","key":"key\n\t\t\t\t20180618200125_CIT0026","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"key\n\t\t\t\t20180618200125_CIT0027","first-page":"332","article-title":"Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis","volume":"45","author":"Hadfield","year":"2008","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20180618200125_CIT0028","first-page":"9","article-title":"SMARCB1\/INI1 germline mutations contribute to 10% of sporadic schwannomatosis","volume":"11","author":"Rousseau","year":"2011","journal-title":"BMC Neurol"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0029","first-page":"141","article-title":"Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis","volume":"13","author":"Smith","year":"2012","journal-title":"Neurogenetics"},{"issue":"4","key":"key\n\t\t\t\t20180618200125_CIT0030","first-page":"358","article-title":"Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis","volume":"74","author":"Boyd","year":"2008","journal-title":"Clin Genet"},{"issue":"9","key":"key\n\t\t\t\t20180618200125_CIT0031","first-page":"373","article-title":"SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors","volume":"207","author":"Smith","year":"2014","journal-title":"Cancer Genet"},{"issue":"3","key":"key\n\t\t\t\t20180618200125_CIT0032","first-page":"216","article-title":"Familial schwannomatosis with a germline mutation of SMARCB1 in Japan","volume":"32","author":"Asai","year":"2015","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0033","first-page":"129","article-title":"The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum Genet"},{"issue":"7","key":"key\n\t\t\t\t20180618200125_CIT0034","first-page":"963","article-title":"Expanding the mutational spectrum of LZTR1 in schwannomatosis","volume":"23","author":"Paganini","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0035","first-page":"141","article-title":"Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis","volume":"84","author":"Smith","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"key\n\t\t\t\t20180618200125_CIT0036","first-page":"227","article-title":"Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas","volume":"29","author":"Sestini","year":"2008","journal-title":"Hum Mutat"},{"issue":"1","key":"key\n\t\t\t\t20180618200125_CIT0037","first-page":"87","article-title":"Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis","volume":"88","author":"Smith","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"key\n\t\t\t\t20180618200125_CIT0038","first-page":"e0129099","article-title":"A systematic assessment of accuracy in detecting somatic mosaic variants by deep amplicon sequencing: Application to NF2 gene","volume":"10","author":"Contini","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618200125_CIT0039","article-title":"Determination of the mutant allele frequency in patients with neurofibromatosis type 2 and somatic mosaicism by means of deep sequencing","author":"Spyra","year":"2015","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/20\/7\/917\/25061972\/noy009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T20:06:01Z","timestamp":1529352361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/20\/7\/917\/4835073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,2,2]]},"published-print":{"date-parts":[[2018,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noy009","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,2,2]]}}}